Biolargo, Inc.
BLGO
Revenue
198.17k
▲26.13k▲15.19%
3 Months ChangeAssets
10.05M
▲232.00k▲2.36%
3 Months ChangeLiabilities
4.16M
▼-512.00k▼-10.96%
3 Months ChangeFree Cash Flow
-1.01M
▼-1.01M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-15
Form 8-K
ID: 0001437749-24-026919
2024-08-14
Form 10-Q
ID: 0001437749-24-026827
2024-06-20
Form 8-K
ID: 0001437749-24-020750
2024-06-13
Form 8-K
ID: 0001437749-24-020181
2024-05-15
Form 8-K
ID: 0001437749-24-016762
2024-05-14
Form 10-Q
ID: 0001437749-24-016682
2024-01-22
Form 8-K
ID: 0001437749-24-001796
2024-01-10
Form 8-K
ID: 0001437749-24-001078
2024-01-05
Form 8-K
ID: 0001437749-24-000717
2023-11-21
Form 8-K
ID: 0001437749-23-032675